OMERS ADMINISTRATION Corp Reduces Stock Position in Colgate-Palmolive Company $CL

OMERS ADMINISTRATION Corp cut its holdings in Colgate-Palmolive Company (NYSE:CLFree Report) by 0.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 1,683,240 shares of the company’s stock after selling 14,832 shares during the period. OMERS ADMINISTRATION Corp’s holdings in Colgate-Palmolive were worth $133,010,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of CL. CBIZ Investment Advisory Services LLC raised its position in shares of Colgate-Palmolive by 86.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock worth $26,000 after acquiring an additional 150 shares in the last quarter. Triumph Capital Management boosted its holdings in Colgate-Palmolive by 62.9% in the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock valued at $26,000 after purchasing an additional 127 shares in the last quarter. Jessup Wealth Management Inc acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $26,000. Maseco LLP acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. Finally, Motiv8 Investments LLC acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $27,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

CL stock opened at $90.59 on Tuesday. The company has a market capitalization of $72.49 billion, a P/E ratio of 35.25, a PEG ratio of 4.72 and a beta of 0.33. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The business has a 50 day simple moving average of $86.96 and a 200-day simple moving average of $86.38. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The company’s revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.91 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.81 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, July 20th. Colgate-Palmolive’s dividend payout ratio is presently 82.49%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on CL shares. Sanford C. Bernstein started coverage on Colgate-Palmolive in a report on Thursday. They issued a “market perform” rating and a $96.00 price target for the company. UBS Group upped their price target on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a report on Monday, May 4th. Piper Sandler lowered their price target on Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $99.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. Twelve equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $95.88.

View Our Latest Analysis on CL

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.